Fordyce Marshall - Insider Transactions
Insider Type
individual
Companies
1
Average
196,457
Total Txns
54
Long-Term
Annual Transaction Insights
| Year | Buy | Sell | Δ | Buy, USD | Sell, USD | Δ |
|---|---|---|---|---|---|---|
| 2024 | 0 | 48 | -48 | 0.00 | 9,331,213.69 | -9,331,213.69 |
| 2025 | 0 | 6 | -6 | 0.00 | 1,277,449.08 | -1,277,449.08 |
| Total: | 0 | 54 | 10 | 0.00 | 10,608,662.77 | -10,608,662.77 |
Transactions
| Company | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Vera Therapeutics, Inc. Class A Common Stock US92337R1014 |
28.32 USD |
1,100 Sold |
31,150 USD |
21/02/2025 | 26/02/2025 |
| Vera Therapeutics, Inc. Class A Common Stock US92337R1014 |
27.55 USD |
7,975 Sold |
219,732 USD |
21/02/2025 | 26/02/2025 |
| Vera Therapeutics, Inc. Class A Common Stock US92337R1014 |
27.89 USD |
10,613 Sold |
296,032 USD |
21/02/2025 | 21/02/2025 |
| Vera Therapeutics, Inc. Class A Common Stock US92337R1014 |
41.53 USD |
9,975 Sold |
414,297 USD |
08/01/2025 | 08/01/2025 |
| Vera Therapeutics, Inc. Class A Common Stock US92337R1014 |
42.03 USD |
5,650 Sold |
237,489 USD |
08/01/2025 | 08/01/2025 |
| Vera Therapeutics, Inc. Class A Common Stock US92337R1014 |
42.00 USD |
1,875 Sold |
78,750 USD |
08/01/2025 | 08/01/2025 |
| Vera Therapeutics, Inc. Class A Common Stock US92337R1014 |
43.52 USD |
5,023 Sold |
218,610 USD |
18/12/2024 | 18/12/2024 |
| Vera Therapeutics, Inc. Class A Common Stock US92337R1014 |
44.03 USD |
4,635 Sold |
204,094 USD |
18/12/2024 | 18/12/2024 |
| Vera Therapeutics, Inc. Class A Common Stock US92337R1014 |
41.33 USD |
3,772 Sold |
155,883 USD |
18/12/2024 | 18/12/2024 |
| Vera Therapeutics, Inc. Class A Common Stock US92337R1014 |
43.81 USD |
1,875 Sold |
82,144 USD |
18/12/2024 | 18/12/2024 |